Not Applicable
Not Applicable
Not Applicable
1. Field of the Invention
The present invention relates to pharmaceutical packaging, more particularly, to single dose packaging for children's medications.
2. Description of the Related Art
Acetaminophen is an analgesic that is safe and effective for children when taken in recommended dosages. However, it can cause liver damage and other health issues if taken in too great a quantity, either at one time or over time. The appropriate dose of acetaminophen for a child is typically determined by the child's weight, generally in milliliters per range of weight. An example of such dosing is the dosing chart for Children's TYLENOL acetaminophen, shown in
Liquid acetaminophen for children is available in multiple dose bottles. For administering to a child, the appropriate dose is poured into a small, graduated cup, from which the child drinks, or is drawn into an oral syringe that is expelled into the child's mouth. With both methods, it is difficult to get the exact amount into the child. The graduations on the cup are close together and difficult to read. The liquid in a syringe can have bubbles and the liquid in the neck at the orifice is typically not expelled.
Overdosing a child can happen in a number of different ways. If the caregiver is in a hurry, he/she may not measure as accurately as necessary. The caregiver may inadvertently use an adult formulation rather than a child formulation. If the bottle is left open, the child may mistakenly believe that the acetaminophen as something that is safe to drink.
Multiple dose bottles can also have issues with contamination. Inserting a used syringe into the bottle can contaminate the liquid if it is not cleaned properly. Touching the inside of the bottle or the cap can cause contamination. Leaving the bottle open for a period of time can cause the liquid to become contaminated. Contaminated medicine in a multi-dose bottle can spread diseases.
The present invention is a dosing system for analgesic liquid suspensions where unit dose containers are made for specific weight ranges of children in order to prevent overdosing and contamination, and for ease in administering to the child.
The containers are made using blow-fill-seal (BFS) technology. In one configuration, there are four different sizes for the unit dose container: a 15 ml container, a 7.5/10 ml container, a 3.75/5 ml container, and a 1.25/2.5 ml container. Each container holds an appropriate dose for a particular weight range.
Each container has body with a compartment for holding the liquid, opposed finger rests for squeezing the container to expel the liquid, a tab at one end of the body for labeling, and a twist-off closure at the other end of the body that covers the opening of a passage through which the liquid is expelled.
In the larger containers, the end of the body with the opening has a lip rest, which is a flattened section that includes opposed, curved depressions. The smallest container has a long tapered neck through which the passage extends.
The analgesic suspension has a relatively low viscosity that flows more easily than the suspensions of the prior art. This ensures more complete dose evacuation from the container, thereby ensuring more accurate dosing.
The present invention contemplates that the containers will be sold in assemblages of various combinations of sizes. In one combination, there is one container of each size. In another combination, there are different numbers of containers of each size. In another combination, all the containers are the same size.
Objects of the present invention will become apparent in light of the following drawings and detailed description of the invention.
For a fuller understanding of the nature and object of the present invention, reference is made to the accompanying drawings, wherein:
The present invention is a dosing system for analgesic liquid suspensions where unit dose containers are made for specific weight ranges of children in order to prevent overdosing and contamination, and for ease in administering to the child.
Preferably, the containers are made using blow-fill-seal (BFS) technology. Pharmaceutical-grade plastic resin, such as low-density polyethylene, is heat extruded through a circular throat to form a hanging tube. The tube is enclosed by a two-part mold and inflated to form a container within the mold. The container is filled with the analgesic suspension and a secondary mold seals the container. The process takes place inside a class 100 shroud inside the BFS machine. The sealed container is discharged for labeling, packaging. and distribution. Optionally, the containers are overwrapped with a foil/poly film to provide better stability and flavor retention during transportation and storage.
In one configuration of present invention, there are four different sizes for the unit dose container: a 15 ml container 10a, a 7.5/10 ml container 10b, a 3.75/5 ml container 10c, and a 1.25/2.5 ml container 10d (collectively, 10), shown in
The containers 10 and doses described above work well for an acetaminophen suspension. The present invention, however, contemplates that the present invention can be used with other analgesics, and thus with different size containers 10, different analgesic concentrations, and different doses. A person of skill in the art will know how to adjust the container sizes, concentrations, and/or doses as needed for different analgesics.
The different size containers 10 have several common elements. Each container 10 has body 12 with a compartment 14 for holding the liquid. The size of the compartment 14, of course, depends on how much liquid the particular container 10 is to hold. In the current configuration, the 15 ml container 10a has a total volume of 17 ml±0.5 ml, the 7.5/10 ml container 10b has a total volume of 12 ml±0.5 ml, the 3.75/5 ml container 10c has a total volume of 7 ml±0.5 ml, and the 1.25/2.5 ml container 10d has a total volume of 5 ml±0.5 ml.
Each container 10 has opposed finger rests 16 for squeezing the container 10 to expel the liquid. The finger rests 16 are rounded indentations in the sides 18 of the body 12 outside of the compartment 14. Optionally, the finger rests 16 are textured to provide a non-slip grip. The texturing can include a plurality of ridges 20.
Each container 10 has a tab 22 at one end of the body 12. The tab 22 can be use for labeling or other functions. Typically, the lot number and expiration date will be on the tab 22. Other identifying information, such as a trademark, may also be on the tab 22.
Each container 10 has a twist-off closure 24 at the other end of the body 12. The closure 24 covers an opening 26 of a passage 28 through which the liquid is expelled from the compartment 14 during administration. The closure 24 is removed by twisting it around the longitudinal axis 30 of the container 10 until it snaps off, thereby exposing the opening 26. The opening 26 will be in the range from about 0.08 inch to about 0.15 inch.
In the larger containers 10a, 10b, 10c of
The 1.25/2.5 ml container 10d, 10e of
The relatively high-viscosity (“thick”) analgesic suspension, on the order of 716 centipoises (cP), used in the prior art tends to adhere thickly to the sides of the dosing cup so that not all of the medication is administered to the child. The present invention uses a relatively low-viscosity (“thin”) analgesic suspension. The thin suspension flows more easily and adheres thinly to the sides of the container. This ensures more complete dose evacuation from the container, thereby ensuring more accurate dosing. The present invention contemplates a viscosity in the range of 300 to 1500 cP with a preferred range of 650 to 700 cP and a preferred value of 681 cP.
The present invention contemplates that the containers 10 will be sold in assemblages of various combinations of sizes. In one combination, the assemblage includes one container of each size. In another combination, the assemblage includes different numbers of containers of each size. In another combination, the assemblage includes a plurality of containers of the same size.
Thus it has been shown and described a packaging system for liquid medications.
Since certain changes may be made in the present disclosure without departing from the scope of the present invention, it is intended that all matter described in the foregoing specification and shown in the accompanying drawings be interpreted as illustrative and not in a limiting sense.
Number | Name | Date | Kind |
---|---|---|---|
3917120 | Larenz et al. | Nov 1975 | A |
3993223 | Welker et al. | Nov 1976 | A |
4078566 | Urban, Jr. | Mar 1978 | A |
4512475 | Federighi | Apr 1985 | A |
D309097 | Price | Jul 1990 | S |
5009309 | Hansen | Apr 1991 | A |
D330160 | Umekawa | Oct 1992 | S |
5409125 | Kimber et al. | Apr 1995 | A |
D362390 | Weiler | Sep 1995 | S |
5587177 | Grimberg | Dec 1996 | A |
D379663 | Pearson et al. | Jun 1997 | S |
6173852 | Browne | Jan 2001 | B1 |
6234333 | Federighi et al. | May 2001 | B1 |
6241124 | Hoyt | Jun 2001 | B1 |
6276533 | Kaplan | Aug 2001 | B1 |
D492028 | Masuda et al. | Jun 2004 | S |
D492406 | Masuda et al. | Jun 2004 | S |
6860405 | Poynter | Mar 2005 | B1 |
D515936 | Ko | Feb 2006 | S |
D517207 | Poynter | Mar 2006 | S |
7032590 | Loeffler et al. | Apr 2006 | B2 |
D539903 | Strong | Apr 2007 | S |
D544644 | Hartstock et al. | Jun 2007 | S |
D544958 | Wurtz et al. | Jun 2007 | S |
D565193 | Price | Mar 2008 | S |
D571002 | Starnes | Jun 2008 | S |
7487894 | Zahn et al. | Feb 2009 | B2 |
7607541 | Girgis et al. | Oct 2009 | B2 |
D641642 | Caldwell et al. | Jul 2011 | S |
D666289 | DeCoste | Aug 2012 | S |
20040024372 | Grogan | Feb 2004 | A1 |
20040094449 | Schmid | May 2004 | A1 |
20050202085 | Lovercheck | Sep 2005 | A1 |
20080000798 | Gutmann et al. | Jan 2008 | A1 |
20080083691 | Poynter et al. | Apr 2008 | A1 |
20090101650 | Hansen | Apr 2009 | A1 |
20100163577 | Hansen | Jul 2010 | A1 |
Entry |
---|
Romelag Product No. 2048 Ampule, Jun. 6, 1990, (1 page). |
Romelag Drawing No. 3682A-A25B60, Jun. 13, 2007, (1 page). |
Romelag Drawing No. 3682A-A09B60, Jun. 13, 2007, (1 page). |